Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Overview of attention for article published in Journal of Clinical Oncology, May 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 3 news outlets
blogs: 3 blogs

twitter: 7 X users

Readers on

mendeley: 66 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 108,383 followers.

小児高悪性度中枢神経系腫瘍に対するインターロイキン-7受容体導入GD2.CAR-T細胞療法の第I相試験 /J Clin Oncol. 2024 Aug 10;42(23):2769 /NCT04099797 ✓解析対象はCAR-T治療を受けた全11例 ✓年齢中央値12歳 ✓DMG8例（視床4、橋3、脊髄1）、髄芽腫2例、AT/RT1例 https://t…

RT @InnovOncology: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.